It has been well established in a variety of organisms that gene mutations affect the formation of specific enzymes. In view of the complexity of the gene in terms of numbers of distinct mutational sites,1 it might be expected that different changes within any one gene would result in different alterations of a specific enzyme or protein. Some enzyme alterations have, in fact, been associated with gene changes,2-5 and, in one case, a single amino acid substitution has been shown to distinguish the mutant from the normal form of a protein. These instances strengthen the view that the amino acid sequence of each protein may reflect the arrangement of the subunits of its determining gene.
In Neurospora, certain mutants defective in the ability to form the enzyme tryptophan synthetase (TSase) are distinguishable from one another on the basis of analyses of the following types: growth in the absence of tryptophan, accumulation of intermediates, reversion frequency, response or lack of response to specific suppressor genes, enzyme activity measurements, and immunological comparisons.7-11 Since these strains represent mutations of the same gene and are distinguishable from one another, it may be assumed that in some cases the dissimilarities detected result from different alterations of TSase. In this regard the immunological findings are of particular interest because they demonstrate that certain of these mutants form a protein (designated CRM) which may be an inactive or incomplete form of TSase.'0 This protein is immunologically similar to TSase and is absent from at least one mutant which lacks TSase.0" ,l Whether the CRM's formed by distinguishable mutant types differ from one another has not been determined, but differences might be expected if the CRM's represent altered forms of TSase.
Studies with the analogous system in Escherichia coli have shown that mutants lacking TSase fall into the same two groups, viz., those which form a cross-reacting protein (CRM) and those which do not.'2 In E. coli, mutants in the latter group have two additional characteristics which distinguish them from strains which form CRM; they accumulate indoleglycerol instead of indole,'2, 13 and they lack an enzyme required for the conversion of indoleglycerol phosphate to indole.'4 The absence from these mutants of both CRM and an enzyme involved in the synthesis of indole suggested a second interpretation of the nature of CRM, viz., that it is an enzyme catalyzing an earlier step in tryptophan synthesis.12 This report is concerned with a study of this possibility.
MATERIALS AND METHODS
The characteristics of the various mutant strains of E. coli employed in this 245 study are summarized in Table 1 , in which the probable pathway of tryptophan synthesis in this organism is also indicated. With the exception of the stocks designated "B" (derived from the B strain of E. coli), the mutants listed were obtained from the K-12 strain of E. coli. Mutant T-3 was considered equivalent to the wild type for the purposes of this study. It forms large amounts of TSase and the other enzymes involved in tryptophan synthesis when grown on low levels of anthranilic acid. 14 Preparation of Antisera.-Antibodies were produced in rabbits in response to the injection of partially purified preparations of TSase or CRM.12 The antisera were heated for 30 minutes at 560, fractionated with ammonium sulfate, and then dialyzed before use. In some cases, antisera were repeatedly treated with portions of extracts of K-12 mutants (T-84 and T-41) lacking both CRM and TSase to remove antibodies to other coli antigens. The absorbed antisera were then heated, fractionated with ammonium sulfate, and dialyzed before use.
Neutralization of TSase.-Antibodies to TSase or to CRM are capable of completely neutralizing TSase activity.'2 Over a considerable portion of the neutralization curve (see Fig. 1 ), however, some of the enzyme is precipitated without being neutralized (from 0.08 to 0.2 ml. antiserum). It is also evident from Figure 1 that the amount of enzyme activity remaining in the supernatant solution decreases linearly as increasing amounts of antiserum are added. As previously reported,12 15 minutes is sufficient for an antiserum to exert its maximal inhibitory effect. Neutralization of Component B.-Antisera to TSase or to CRM, whether absorbed or not, are capable of precipitating component B. However, only a fraction of the B activity which is precipitated by antibody is neutralized. '7 In determinations of antibody-component B interactions, therefore, precipitates were removed by centrifugation (following 40-hour incubations), and only supernatant solutions were assayed for component B activity.
Immunological Assay of CRM.-Two methods were used for estimating the amount of CRM in various mutant extracts and preparations. In the fir-st method, unknown amounts of CRM were preincubated with an excess of antibody, and, -after a suitable period, the amount of antibody remaining unneutralized was determined. 12 In the second or "competition" method, aliquots of CRM solutions VOL. 44, 1958 247 were thoroughly mixed with a known amount of TSase prior to the addition of antibody. Antibody was then added, and the reduction in neutralization of TSase activity resulting from the presence of CRM was determined. In this assay procedure, which gave more reproducible results than the first method, one unit of CRM was defined as the amount of material which was antigenically equivalent to (i.e., would combine with as much antibody as) one unit of TSase. The theoretical curve based on this assumption is shown in Figure 2 , as well as the experimental points obtained in a typical titration of the CRM in an extract of mutant td4. Assays by the second method were reproducible to within 10-20 per cent, and this procedure was accordingly used in instances where a quantitative titration of CRM was desired. CRM specific activity is expressed in units of CRM per milligram protein.
RESULTS
In initial studies on formation of indole from indoleglycerol phosphate by mutant extracts it became apparent that at least two enzymes are required for this conversion. This is illustrated by the data in Table 2 . Extracts of neither strain T-84 nor strain T-8 alone were capable of converting indoleglycerol phosphate to indole. A mixture of these two extracts, however, rapidly carried out this conversion. We have arbitrarily designated the active T-84 and T-8 components as A and B, respectively. It can also be seen from Table 2 that extracts of wild-type strains contain two distinct components, both of which are essential for the conversion of indoleglycerol phosphate to indole. One of these components, A (determined by mixing experiments with T-84 and T-8 extracts), remains in the supernatant solution when extracts are treated with acetic acid until precipitation just occurs. The second component, B, is more stable than A to heating at 600. Sensitivity of B and CRM to heat and alkaline pH was tested and both B and CRM were found to be affected to the same extent (see Table 5 Fig. 2. t It may be-a*od that this ratio is exactly the same as the B/CRM ratios obtained with extracts of mutants td2, td4, an4 WA, This findiing indicates that, per unit of antigenic material, there is as much B activity in mutants as ift-the-wild-type strain.
In a further study, neutralization of the TSase in a T-4 extract was compared with neutralization of a mixture containing T-3 TSase and td2 B in amounts which reproduced exactly the B/TSase ratio of the T4 extract. The results of this experiment (Fig. 3) show that the T-4 TSase and the TSase in the T-3-td2 mixture were both inhibited to the same extent by the antiserum employed.
Comparison of the Neutralization of B and CRM.-In other experiments, the precipitation of component B and CRM by absorbed antisera was compared. The results of two such experiments are presented in Figure 4 . Both CRM and component B were affected to approximately the same extent by increasing amounts of antiserum, and both were completely removed at the same point. In similar tests, antiserum to td2-CRM (absorbed) also precipitated both CRM and component B to the same extent. When excesses of antibody were incubated (2 In evaluating this conclusion in terms of the relationship between CRM (B) and TSase, two possibilities are being considered: (a) that CRM (B) and TSase are distinct but closely related proteins and (b) that one protein normally exhibits both activities (B and TSase) and that CRM is a mutationally altered form of this protein that retains only component B activity.
The different types of mutants which have been obtained (lacking component B and/or TSase) are of importance in considering the foregoing possibilities. These classes and the class lacking component A are indicated in Table 7 , together with the mutants present in each. Although the mutants listed were obtained in several laboratories and from two wild-type strains of E. coli, one class of mutants is noticeably absent, the class lacking component B alone. This class is replaced by a category containing strains in which both component B and TSase are absent. All nine of the mutants in this class have been examined in reversion experiments, and all do revert. However, when they do, both activities are invariably regained at the same time. It would appear, therefore, that these strains represent instances in which two enzymatic activities are lost and regained as a result of single mutational events. The fourth category in Table 7 includes mutants in which portions of the genic region controlling tryptophan biosynthesis have been lost by deletions; their behavior is not relevant to present considerations. The available data do not exclude the possibility, however, that both component B activity and TSase activity are associated with the same protein and that the formation of this protein is controlled by a single gene. Mutations within this gene could presumably affect it so that the ability to form the protein bearing both activities is lost or, when less drastic, could affect only the portion of the gene concerned with the TSase reaction. To explain the absence of mutants lacking component B alone, it may be assumed that mutations in the genic region which affects B activity result in protein alterations which eliminate both the immunological identity and the TSase activity of the protein. Consistent with this interpretation is the possibility suggested by recent studies with Neurospora20 that the formation of tryptophan from indoleglycerol phosphate (or a compound derived from indoleglycerol phosphate) occurs on one enzyme surface, with enzyme-bound indole generated from indoleglycerol phosphate serving as the true intermediate rather than free indole.
Studies designed to distinguish between the alternative possibilities are now in progress.
SUMMARY
Enzymatic and immunological studies with mutants of E. coli have provided evidence suggesting that the cross-reacting protein related to tryptophan synthetase can catalyze a reaction involved in the conversion of indoleglycerol phosphate to indole. The possibility that this reaction and the coupling of indole and serine are normally catalyzed by the same enzyme, tryptophan synthetase, is discussed.
The 
